Vir Biotechnology Inc.

10.49
0.21 (2.04%)
At close: Jan 28, 2025, 2:36 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -615.06M 515.84M 528.58M -298.67M -174.68M -115.88M -69.85M
Depreciation & Amortization 19.45M 6.78M 5.81M 5.44M 4.52M 2.76M 432.00K
Stock-Based Compensation 111.32M 102.08M 83.78M 27.60M 8.72M 5.05M 4.78M
Other Working Capital -305.32M -105.47M 92.04M 30.31M 7.24M 11.02M 2.85M
Other Non-Cash Items 11.16M 388.37M -52.56M 45.21M 8.95M 1.97M 4.32M
Deferred Income Tax -1.06M -15.19M 15.19M -52.00K 14.66M -480.00K -10.92M
Change in Working Capital -304.59M 665.37M -628.39M 29.52M 8.20M 12.49M 4.86M
Operating Cash Flow -778.78M 1.66B -47.59M -190.94M -129.63M -94.10M -66.38M
Capital Expenditures -21.57M -68.03M -21.82M -6.55M -8.94M -8.19M -2.74M
Acquisitions n/a 22.00K 140.81M 180.00K 247.22M 25.00K -27.25M
Purchase of Investments -2.02B -1.48B -420.24M -403.84M -643.90M -123.11M n/a
Sales Maturities Of Investments 2.20B 351.51M 301.24M 400.35M 396.68M 72.57M n/a
Other Investing Acitivies n/a -1.13B -140.81M 180.00K -247.22M -1.74M n/a
Investing Cash Flow 164.63M -1.19B -140.81M -9.86M -256.16M -60.44M -29.99M
Debt Repayment -287.00K -260.00K -259.00K -250.00K 4.37M n/a n/a
Common Stock Repurchased n/a n/a n/a n/a -3.00K n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 7.77M 6.56M 15.38M -189.00K 444.88M 24.98M 271.18M
Financial Cash Flow 7.48M 34.76M 100.33M 529.47M 449.24M 24.98M 271.18M
Net Cash Flow -606.68M 504.55M -88.07M 328.67M 63.45M -129.56M 174.81M
Free Cash Flow -800.36M 1.60B -69.41M -197.49M -138.57M -102.29M -69.12M